April 21, 2020 – Telus Health Canada may see its first gene therapy by the end of this year. The treatment is for a very
March 5, 2020 On the surface the number of patients switching to a biosimilar biologic during phase two of the B.C. government’s Biosimilars Initiative, launched in
Alberta Biosimilar InitiativeOn December 12, 2019, the Alberta government introduced the launch of the Alberta Biosimilar Initiative. This program will require patients using several originator
BC PharmaCare announced last month the launch of a new Biosimilars Initiative. The program took effect on May 27, 2019 and will require patients using
February 28th, 2018 On December 1, 2017 the Canadian Federal Ministry of Health proposed changes to the drug pricing regulations in an effort to protect